Work with us - helping you translate the best biomedical science to deliver better health for all, safely and efficently.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum consequat felis eu elit facilisis, sed posuere magna suscipit. Fusce urna elit, placerat quis blandit quis, mattis id ipsum. Vivamus ...

Colin Mitchell sets out why our work to clarify the impact of the GDPR on the use of genomic data is so necessary. The work is funded by the Information Commissioner's Office ...

The UK government has launched a new alliance to sequence the genomes of SARS-CoV-2, the virus responsible for the current COVID-19 pandemic. Backed by a £20 million investment, the COVID-19 Genomics ...

Across these two policy briefings, we outline what functional genomics is, the approaches used in this field and explore the potential impact of functional genomics on clinical medicine.

A new type of medicine that uses an approach called ‘gene silencing’ has been approved for use in the NHS in England.

It’s been quite a wait, but the much-anticipated National Genomics Healthcare Strategy, has now landed. GENOME UK: The future of healthcare sets out plans to use genomics to drive improvements in ...

We are getting closer to a world where the debilitating pain and complications of sickle cell disease are a thing of the past. For the 17,500 people in the UK living with this genetic condition, this ...

The ACMG has provided a useful and timely reminderthat there is some way to go before polygenic scores can be used routinely in healthcare.

Antimicrobial resistance (AMR) is one of the greatest challenges facing health systems, causing an estimated 4.71 million deaths globally in 2021. It has been ten years since the World Health ...

With the recent launch of its infectious diseases strategy, Public Health England (PHE) has outlined is ambitions for the next five years in terms of its core mission “to prevent, detect, respond to ...

To deliver PGS-based tests or assays into clinical care effectively and efficiently, policy-makers need clarity about these technologies.